Compass Therapeutics, Inc. Common Stock
CMPX
Closed
$2.02
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in Boston, Massachusetts and currently employs 39 full-time employees. The company went IPO on 2020-11-13.
Country
US
CEO
Dr. Thomas Schuetz
IPO date
2020
Employees
39
ISIN
US20454B1044
Website
Key stats
Open
$2.00
Volume
3.59M
Market cap
$361.98M
Prev. close
$2.00
Impl / hst vl
-
Open interest
$0.00
$1.97
Day’s Range
$2.08
$1.61
52W Range
$6.88
Valuation
33
Valuation score
Overvalued
P/E
-
P/S
-
P/B
5.11
Current ratio
19.04
Debt / Equity
-0.30
ROE
-
Gross margin
-
Income growth
-
FCF growth
30.91
Analysts estimates
Consensus rating
Buy
The average rating from top 10 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$8.99
The top 13 analysts forecasts that 12-month price may increase by 345.28%, with a low of $4.04 and a high of $25.20
$4.04
Low
$8.99
Avg
$25.20
High
Current price
Earnings
Q4 ‘25 revenue
$0.00
Q4 ‘25 net income
-$15.72M
Revenue
Net income
Previous EPS
-$0.09
Estimate EPS
-$0.10
Actual EPS
Estimate EPS
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply